Stock 6461 INTECH BIOPHARM CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Company Intech Biopharm Corporation

Equities

6461

TW0006461007

Pharmaceuticals

End-of-day quote Taipei Exchange
Other stock markets
 03:30:00 14/05/2024 am IST 		5-day change 1st Jan Change
27.15 TWD -0.18% Intraday chart for Intech Biopharm Corporation -0.18% -9.20%
13/03 Intech Biopharm Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Intech Biopharm Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Business Summary

INTECH BIOPHARM LTD. is a Taiwan-based company principally engaged in the research, development, manufacture and sales of inhalants and related products. The Company's main products include respiratory drugs, the Duasma hexafluoroacetone (HFA) metered-dose inhalers (MDIs) and the Synvent HFA MDIs. The Company distributes its products in domestic market and to overseas markets.

Number of employees: 82

Sales per Business

TWD in Million2022Weight2023Weight Delta
Drugs for Obstructive Airway Diseases
100.0 %
24 100.0 % 26 100.0 % +9.30%

Sales per region

TWD in Million2022Weight2023Weight Delta
Taiwan
84.5 %
11 44.9 % 22 84.5 % +105.91%
Hong Kong
6.8 %
1 3.9 % 2 6.8 % +89.99%
Other
4.4 %
-- 1 4.4 % -
China
4.3 %
9 39.4 % 1 4.3 % -87.99%

Managers

Managers TitleAgeSince
Wei Hsiu Wu CEO
 Chief Executive Officer - 01/11/01
Chien Yao Yang DFI
 Director of Finance/CFO - 23/13/23
Chih Hui Lin CHM
 Chairman - 28/10/28
Yan-Qin Zhao CTO
 Chief Tech/Sci/R&D Officer - 27/19/27
Steve Pi IRC
 Investor Relations Contact - -

Members of the board

Members of the board TitleAgeSince
Chih Hui Lin CHM
 Chairman - 28/10/28
Te Chien Chou BRD
 Director/Board Member 66 02/14/02
Wei Hsiu Wu CEO
 Chief Executive Officer - 01/11/01
Hsiu Mei Lin BRD
 Director/Board Member - 11/15/11
Te Chuan Fan BRD
 Director/Board Member 41 11/15/11
Fang Ping Chen BRD
 Director/Board Member - 23/17/23
Hui Lan Chiu BRD
 Director/Board Member - 22/21/22
Chi-Rui Li BRD
 Director/Board Member - 03/22/03
De-Ren Liu BRD
 Director/Board Member - -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 137,409,000 69,661,500 ( 50.70 %) 0 50.70 %

Company contact information

Intech Biopharm Ltd.

3/F No. 36, Lane 358, Ruiguang Road

11492, Taipei

+

http://www.intechbiopharm.com
address Intech Biopharm Corporation(6461)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Specialty & Advanced Pharmaceuticals

Sales per region

Sector Specialty & Advanced Pharmaceuticals

1st Jan change Capi.
INTECH BIOPHARM CORPORATION Stock Intech Biopharm Corporation
-9.20% 115M
MERCK KGAA Stock Merck KGaA
+9.85% 72.5B
KYOWA KIRIN CO. LTD. Stock Kyowa Kirin Co. Ltd.
+13.69% 9.11B
SK BIOPHARMACEUTICALS CO., LTD. Stock SK Biopharmaceuticals Co., Ltd.
-12.85% 5.07B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD. Stock Shenyang Xingqi Pharmaceutical Co.,Ltd.
+60.16% 5.01B
YUHAN CORPORATION Stock Yuhan Corporation
+1.60% 3.85B
BETTA PHARMACEUTICALS CO., LTD. Stock Betta Pharmaceuticals Co., Ltd.
-19.20% 2.46B
INDIVIOR PLC Stock Indivior PLC
+18.65% 2.44B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. Stock Shanghai Shyndec Pharmaceutical Co., Ltd.
+24.62% 2.27B
CHANGCHUN BCHT BIOTECHNOLOGY CO. Stock Changchun BCHT Biotechnology Co.
-27.46% 2.26B
Specialty & Advanced Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 6461 Stock
  4. Company Intech Biopharm Corporation
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW